Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
WITHDRAWN
NCT03972111

A Phase 4, Observational Field Study to Evaluate TPOXX in Patients With Smallpox

Sponsor: SIGA Technologies

View on ClinicalTrials.gov

Summary

Phase 4, Observational Field Study in Patients Treated With TPOXX for Smallpox Disease

Official title: A Phase 4, Observational Field Study to Evaluate the Safety and Clinical Benefit of TPOXX (Tecovirimat)-Treated Patients Following Exposure to Variola Virus and Clinical Diagnosis of Smallpox Disease

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

0

Start Date

2020-01-01

Completion Date

2024-09-30

Last Updated

2026-09-10

Healthy Volunteers

No

Conditions

Interventions

DRUG

TPOXX 200Mg Capsule

TPOXX 600 mg (three 200 mg.) capsules twice daily for 14 days

Locations (1)

Investigator Site

Corvallis, Oregon, United States